KELLY DAUENHEIMER: Open Payments
NPI 1518424266 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$139 in 6 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $42 · 2025 $139
Food & beverage: $139
| Company | Payments | Amount |
|---|---|---|
| Sage Therapeutics, LLC | 3 | $64 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| MILLICENT US INC | 1 | $21 |
Products named: ZURZUVAE, SCEMBLIX, GVOKE HYPOPEN, INTRAROSA.
Industry payments across AL — which companies pay providers there.
